Company intelligence / Profile preview

Quay Pharma

Deeside, United Kingdom

Ownership: Private
Employees: ~200
Development stage: Other

Overview

Quay Pharma is a UK-based CDMO specializing in formulation development, clinical manufacturing, and support for biotech/pharma from pre-formulation to commercial scale. Now operating as part of SGS following its 2021 acquisition, it focuses on innovative solutions for small molecules, biologics, and live biotherapeutics.

Industry: Contract Manufacturing Organization

Beyond the preview

Go deeper on Quay Pharma.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Quay Pharma.

Explore the full profile